• Mingzhu Meng, Ming Zhang, Dong Shen, and Guangyuan He.
• Department of Radiology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.
• Medicine (Baltimore). 2022 Nov 11; 101 (45): e31214e31214.

AbstractIn order to achieve better performance, artificial intelligence is used in breast cancer diagnosis. In this study, we evaluated the efficacy of different fine-tuning strategies of deep transfer learning (DTL) based on the DenseNet201 model to differentiate malignant from benign lesions on breast dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). We collected 4260 images of benign lesions and 4140 images of malignant lesions of the breast pertaining to pathologically confirmed cases. The benign and malignant groups was randomly divided into a training set and a testing set at a ratio of 9:1. A DTL model based on the DenseNet201 model was established, and the effectiveness of 4 fine-tuning strategies (S0: strategy 0, S1: strategy; S2: strategy; and S3: strategy) was compared. Additionally, DCE-MRI images of 48 breast lesions were selected to verify the robustness of the model. Ten images were obtained for each lesion. The classification was considered correct if more than 5 images were correctly classified. The metrics for model performance evaluation included accuracy (Ac) in the training and testing sets, precision (Pr), recall rate (Rc), f1 score (f1), and area under the receiver operating characteristic curve (AUROC) in the validation set. The Ac of the 4 fine-tuning strategies reached 100.00% in the training set. The S2 strategy exhibited good convergence in the testing set. The Ac of S2 was 98.01% in the testing set, which was higher than those of S0 (93.10%), S1 (90.45%), and S3 (93.90%). The average classification Pr, Rc, f1, and AUROC of S2 in the validation set were (89.00%, 80.00%, 0.81, and 0.79, respectively) higher than those of S0 (76.00%, 67.00%, 0.69, and 0.65, respectively), S1 (60.00%, 60.00%, 0.60, 0.66, and respectively), and S3 (77.00%, 73.00%, 0.74, 0.72, respectively). The degree of coincidence between S2 and the histopathological method for differentiating between benign and malignant breast lesions was high (κ = 0.749). The S2 strategy can improve the robustness of the DenseNet201 model in relatively small breast DCE-MRI datasets, and this is a reliable method to increase the Ac of discriminating benign from malignant breast lesions on DCE-MRI.Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

9 keywords...

hide…